We thank Dr. Hinson for the interest in our article1 and agree that the mechanisms underlying the associations of race and insurance payer with risk of intracerebral hemorrhage recurrence are complex and likely involve social, economic, and structural factors. An inherent limitation of using administrative data sets for purposes other than they were intended is a lack of data on all variables of interest. Although we were not able to test whether medication adherence is a mediator of the observed associations, we agree that it is likely an important factor, regardless of the insurance payer. Previous studies have demonstrated that racial and ethnic differences in antihypertensive medication adherence are modified by insurance status and age, with the largest racial differences in adherence seen among uninsured and young patients.2 As Dr. Hinson acknowledges, well-designed interventions at multiple levels of influence are needed to address barriers to medication adherence and improve racial and ethnic disparities in stroke outcomes.